Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.

Ruhl, Louisa; Kühne, Jenny F; Beushausen, Kerstin; Keil, Jana; Christoph, Stella; Sauer, Jasper; Falk, Christine S

Ruhl, Louisa; Kühne, Jenny F; Beushausen, Kerstin; Keil, Jana; Christoph, Stella; Sauer, Jasper; Falk, Christine S.

Afiliação

Ruhl L; Hannover Medical School, Institute of Transplant Immunology, Hannover, Germany.
Kühne JF; Hannover Medical School, Institute of Transplant Immunology, Hannover, Germany.
Beushausen K; Hannover Medical School, Institute of Transplant Immunology, Hannover, Germany.
Keil J; Hannover Medical School, Institute of Transplant Immunology, Hannover, Germany.
Christoph S; Hannover Medical School, Institute of Transplant Immunology, Hannover, Germany.
Sauer J; Hannover Medical School, Institute of Transplant Immunology, Hannover, Germany.
Falk CS; Hannover Medical School, Institute of Transplant Immunology, Hannover, Germany.

Front Immunol ; 14: 1120010, 2023.

Article em En | MEDLINE | ID: mdl-37033958

Assuntos

Vacinas contra COVID-19; COVID-19; Humanos; SARS-CoV-2; Infecções Irruptivas; COVID-19/prevenção & controle; Imunidade Celular; Imunoglobulina G; Vacinação; Imunoglobulina A

Palavras-chave

COVID-19; SARS-CoV-2 vaccination; T cells; antibodies; breakthrough infection; elderly individuals; omicron; variants of concern

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article